Both in Pharmaceuticals
LB Pharmaceuticals vs Kardigan
Over the past year LBRX returned −11.3% and KARD returned −27.3%; their daily moves had a correlation of 0.45.
LBRX −11.3% KARD −27.3%Growth of $1, one year, split-adjusted
| Metric | LBRX | KARD |
|---|---|---|
| Price | $39.61 | $13.47 |
| Market cap | $1.28B | $1.26B |
| Today | −0.09% | −0.96% |
| 1 month | +6.2% | −8.1% |
| 6 months | +29.5% | — |
| Year to date | +77.9% | — |
| 1 year | +137.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $327.8M | $597.6M |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | — |
| Short % of float | 23.0% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).